Ron Lattanze, MBA, provided his commentary regarding why H.R.2541 or the Nuclear Medicine Clarification Act of 2025 should be passed.
Ron Lattanze, MBA
Advertisement
Articles by Ron Lattanze, MBA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Pertuzumab Biosimilar in Breast Cancer Indications
2
FDA Approves Ziftomenib in R/R NPM1-Mutated Acute Myeloid Leukemia
3
Nivolumab/Ipilimumab Improves Real-World Melanoma Outcomes Vs Pembrolizumab
4
Scorpion Venom Approach May Prove “Powerful” in Glioblastoma Research
5
